tradingkey.logo

Fortrea Holdings Inc

FTRE
17.700USD
-0.210-1.17%
收盘 12/24, 13:00美东报价延迟15分钟
1.63B总市值
亏损市盈率 TTM

Fortrea Holdings Inc

17.700
-0.210-1.17%

关于 Fortrea Holdings Inc 公司

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Fortrea Holdings Inc简介

公司代码FTRE
公司名称Fortrea Holdings Inc
上市日期Jun 16, 2023
CEOThakrala (Anshul)
员工数量15500
证券类型Ordinary Share
年结日Jun 16
公司地址8 Moore Drive
城市DURHAM
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编27709
电话18774950816
网址https://www.fortrea.com/
公司代码FTRE
上市日期Jun 16, 2023
CEOThakrala (Anshul)

Fortrea Holdings Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Mark Morais
Mr. Mark Morais
Chief Operating Officer and President - Clinical Services
Chief Operating Officer and President - Clinical Services
--
--
Mr. William J. (Bill) Sharbaugh
Mr. William J. (Bill) Sharbaugh
Director
Director
--
--
Ms. Erin L. Russell
Ms. Erin L. Russell
Independent Director
Independent Director
--
--
Ms. Hima B. Inguva
Ms. Hima B. Inguva
Investor Relations
Investor Relations
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Peter M. Neupert
Mr. Peter M. Neupert
Chairman of the Board
Chairman of the Board
98.13K
+175.40%
Dr. Amrit Ray, M.D.
Dr. Amrit Ray, M.D.
Lead Independent Director
Lead Independent Director
13.64K
+114.60%
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
Independent Director
Independent Director
13.64K
+114.60%
Mr. David Ross Smith
Mr. David Ross Smith
Independent Director
Independent Director
9.54K
+114.62%
Ms. Machelle Sanders
Ms. Machelle Sanders
Independent Director
Independent Director
7.28K
--
Ms. Jill Mcconnell
Ms. Jill Mcconnell
Chief Financial Officer
Chief Financial Officer
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2021
FY2020
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
North America
344.30M
48.47%
Europe
218.70M
30.79%
Other
147.30M
20.74%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月19日 周三
更新时间: 11月19日 周三
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.71%
The Vanguard Group, Inc.
8.69%
Goldman Sachs & Company, Inc.
8.54%
Corvex Management LP
4.88%
State Street Investment Management (US)
4.41%
其他
59.78%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
13.71%
The Vanguard Group, Inc.
8.69%
Goldman Sachs & Company, Inc.
8.54%
Corvex Management LP
4.88%
State Street Investment Management (US)
4.41%
其他
59.78%
股东类型
持股股东
占比
Investment Advisor
46.30%
Hedge Fund
22.80%
Investment Advisor/Hedge Fund
18.39%
Research Firm
13.93%
Pension Fund
1.41%
Bank and Trust
1.32%
Individual Investor
0.51%
Family Office
0.31%
Holding Company
0.05%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
861
101.77M
121.97%
--
2025Q3
941
101.78M
123.79%
-128.81K
2025Q2
971
101.91M
125.96%
+8.10M
2025Q1
934
96.29M
123.92%
-15.90M
2024Q4
888
96.88M
127.14%
-3.71M
2024Q3
843
100.39M
126.92%
-3.95M
2024Q2
819
103.77M
114.37%
+7.39M
2024Q1
774
92.63M
104.75%
-1.02M
2023Q4
713
91.56M
111.23%
-6.24M
2023Q3
611
90.56M
44.21%
+51.30M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
12.74M
14.03%
+1.79M
+16.37%
Jun 30, 2025
The Vanguard Group, Inc.
8.51M
9.37%
-1.34M
-13.61%
Jun 30, 2025
Goldman Sachs & Company, Inc.
7.74M
8.53%
+7.70M
+19444.90%
Jun 30, 2025
Corvex Management LP
4.51M
4.97%
+33.63K
+0.75%
Jun 30, 2025
State Street Investment Management (US)
4.43M
4.88%
+1.17M
+35.82%
Jun 30, 2025
Sessa Capital
3.99M
4.4%
-700.00K
-14.91%
Jun 30, 2025
AQR Capital Management, LLC
6.52M
7.18%
+5.42M
+494.84%
Jun 30, 2025
Fidelity Management & Research Company LLC
2.98M
3.28%
-1.07M
-26.50%
Jun 30, 2025
Charles Schwab Investment Management, Inc.
1.79M
1.97%
+837.64K
+87.99%
Jun 30, 2025
DWS Investments UK Limited
1.63M
1.79%
+462.75K
+39.79%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Brandes US Small-Mid Cap Value ETF
1.39%
Invesco S&P Spin-Off ETF
0.97%
Invesco S&P SmallCap Health Care ETF
0.58%
Invesco S&P SmallCap 600 Revenue ETF
0.25%
Invesco S&P SmallCap 600 Pure Value ETF
0.23%
Schwab Fundamental U.S. Small Company ETF
0.17%
iShares S&P Small-Cap 600 Value ETF
0.16%
Humankind US Stock ETF
0.14%
ProShares Ultra Nasdaq Biotechnology
0.14%
State Street SPDR S&P 600 Small Cap Value ETF
0.13%
查看更多
Brandes US Small-Mid Cap Value ETF
占比1.39%
Invesco S&P Spin-Off ETF
占比0.97%
Invesco S&P SmallCap Health Care ETF
占比0.58%
Invesco S&P SmallCap 600 Revenue ETF
占比0.25%
Invesco S&P SmallCap 600 Pure Value ETF
占比0.23%
Schwab Fundamental U.S. Small Company ETF
占比0.17%
iShares S&P Small-Cap 600 Value ETF
占比0.16%
Humankind US Stock ETF
占比0.14%
ProShares Ultra Nasdaq Biotechnology
占比0.14%
State Street SPDR S&P 600 Small Cap Value ETF
占比0.13%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Fortrea Holdings Inc的前五大股东是谁?

Fortrea Holdings Inc 的前五大股东如下:
BlackRock Institutional Trust Company, N.A.持有股份:12.74M,占总股份比例:14.03%。
The Vanguard Group, Inc.持有股份:8.51M,占总股份比例:9.37%。
Goldman Sachs & Company, Inc.持有股份:7.74M,占总股份比例:8.53%。
Corvex Management LP持有股份:4.51M,占总股份比例:4.97%。
State Street Investment Management (US)持有股份:4.43M,占总股份比例:4.88%。

Fortrea Holdings Inc的前三大股东类型是什么?

Fortrea Holdings Inc 的前三大股东类型分别是:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Goldman Sachs & Company, Inc.

有多少机构持有Fortrea Holdings Inc(FTRE)的股份?

截至2025Q4,共有861家机构持有Fortrea Holdings Inc的股份,合计持有的股份价值约为101.77M,占公司总股份的121.97%。与2025Q3相比,机构持股有所增加,增幅为-1.82%。

哪个业务部门对Fortrea Holdings Inc的收入贡献最大?

在FY2025Q2,--业务部门对Fortrea Holdings Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI